نتائج البحث - "COLORECTAL cancer"

1

دورية أكاديمية

Maintenance therapy with Fluoropyrimidine and cetuximab or bevacizumab after first line FOLFOX-chemotherapy in metastatic colorectal cancer according to RAS or BRAF^V600E mutation status

المؤلفون: Kang, Sora, Lee, Myung-Won, Song, Ik-Chan, Lee, Hyo-Jin, Yun, Hwan-Jung, Jo, Deog-Yeon, Kim, Jung Sun, Kwon, Jung Hye, Kim, Ji-Yeon, Lee, Kyung-Ha, Ryu, Hyewon^{Aff2, IDs00432023047203_cor11}

المصدر: Journal of Cancer Research and Clinical Oncology. 149(10):7819-7829

Full Text Finder

2

دورية أكاديمية

Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers

المؤلفون: Kim, Sang-A, Park, Hyejoo, Kim, Kui-Jin^{Aff2, IDs00432021038724_cor3}, Kim, Ji-Won^{Aff1, IDs00432021038724_cor4}, Sung, Ji Hea, Nam, Milang, Lee, Ju Hyun, Jung, Eun Hee, Suh, Koung Jin, Lee, Ji Yun, Kim, Se Hyun, Lee, Jeong-Ok, Kim, Jin Won, Kim, Yu Jung, Kim, Jee Hyun, Bang, Soo-Mee, Lee, Jong Seok, Lee, Keun-Wook

المصدر: Journal of Cancer Research and Clinical Oncology. 148(11):2995-3005

Find this article in full text from ProQuest

Full Text Finder

3

دورية أكاديمية

Cetuximab versus bevacizumab in metastatic colorectal cancer: a comparative effectiveness study.

المؤلفون: Marques RP; Faculty of Pharmacy, University of Lisbon, Avenida Professor Gama Pinto, 1649-003, Lisbon, Portugal. rui.p.marques@chln.min-saude.pt.; Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte (CHULN), Lisbon, Portugal. rui.p.marques@chln.min-saude.pt., Godinho AR; Centre for Health Evaluation & Research (CEFAR), Portuguese Pharmacy Association (ANF), Lisbon, Portugal., Heudtlass P; Centre for Health Evaluation & Research (CEFAR), Portuguese Pharmacy Association (ANF), Lisbon, Portugal., Pais HL; Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte (CHULN), Lisbon, Portugal., Quintela A; Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte (CHULN), Lisbon, Portugal., Martins AP; Faculty of Pharmacy, University of Lisbon, Avenida Professor Gama Pinto, 1649-003, Lisbon, Portugal.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2020 May; Vol. 146 (5), pp. 1321-1334. Date of Electronic Publication: 2020 Mar 06.

نوع المنشور: Comparative Study; Journal Article; Observational Study

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

Find this article in full text from ProQuest

Full Text Finder

4

دورية أكاديمية

Conversion surgery after cetuximab or bevacizumab plus FOLFIRI chemotherapy in colorectal cancer patients with liver- and/or lung-limited metastases

المؤلفون: Kim, Sang-A, Kim, Ji-Won^Aff1, Suh, Koung Jin, Chang, Won, Kim, Jin Won, Oh, Heung-Kwon, Cho, Jai Young, Kim, Duck-Woo, Cho, Sukki, Kim, Jee Hyun, Kim, Kwhanmien, Kang, Sung-Bum, Jheon, Sanghoon, Lee, Keun-Wook

المصدر: Journal of Cancer Research and Clinical Oncology. 146(9):2399-2410

Find this article in full text from ProQuest

Full Text Finder

5

دورية أكاديمية

Patient-reported outcomes and health-related quality of life for cetuximab versus bevacizumab in metastatic colorectal cancer: a prospective cohort study.

المؤلفون: Marques RP; Research Institute of Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003, Lisbon, Portugal. rui.p.marques@chln.min-saude.pt.; Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte (CHULN), Lisbon, Portugal. rui.p.marques@chln.min-saude.pt., Heudtlass P; Centre for Health Evaluation and Research (CEFAR), Portuguese Pharmacy Association (ANF), Lisbon, Portugal., Pais HL; Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte (CHULN), Lisbon, Portugal., Quintela A; Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte (CHULN), Lisbon, Portugal., Martins AP; Research Institute of Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003, Lisbon, Portugal.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2019 Jul; Vol. 145 (7), pp. 1719-1728. Date of Electronic Publication: 2019 Apr 29.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

Find this article in full text from ProQuest

Full Text Finder

6

دورية أكاديمية

Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin care.

المؤلفون: Schimanski CC; Medizinische Klinik II, Klinikum Darmstadt GmbH, Grafenstraße 9, 64283, Darmstadt, Germany. Carl.Schimanski@mail.klinikum-darmstadt.de.; iOMEDICO Clinical Research, Hanferstr. 28, 79108, Freiburg, Germany. Carl.Schimanski@mail.klinikum-darmstadt.de., Staib F; Medizinische Klinik II, Klinikum Darmstadt GmbH, Grafenstraße 9, 64283, Darmstadt, Germany., Göhler T; Onkologische Gemeinschaftspraxis Dörfel/Göhler, Leipziger Str. 118, 01127, Dresden, Germany., Hebart H; Klinikum Schwäbisch Gmünd/Stauferklinik, Wetzgauer Straße 85, 73557, Mutlangen, Germany., Heike M; Klinikum Dortmund GmbH, Hohe Straße 31, 44137, Dortmund, Germany., Neise M; Onkologische Gemeinschaftspraxis Dr. M. Neise & Dr. A. Lollert, Marktstraße 186, 47798, Krefeld, Germany., Rudi J; Theresienkrankenhaus, Bassermannstraße 1, 68165, Mannheim, Germany., Geer T; Diakoniekrankenhaus Schwäbisch Hall, Diakoniestraße 10, 74523, Schwäbisch Hall, Germany., Dingeldein G; Onkologische Schwerpunktpraxis Darmstadt, Eschollbrücker Str. 26, 64295, Darmstadt, Germany., Lang C; Kliniken der Stadt Köln GmbH, 51058, Köln, Germany., Ehscheidt P; Praxis für Hämatologie und Onkologie Dr. Ehscheidt, Willi-Brückner-Str. 1, 56564, Neuwied, Germany., Flohr T; Internistische Schwerpunktpraxis Hämatologie/Onkologie, Wallstraße 3-5, 55122, Mainz, Germany., Josten KM; Gemeinschaftspraxis Hämatologie/Onkologie a. d. Dt. Klinik für Diagnostik GmbH, Aukammallee 33, 65191, Wiesbaden, Germany., Karthaus M; Städtisches Klinikum München GmbH Klinikum Neuperlach, Oskar-Maria-Graf-Ring 51, 81737, München, Germany., Schmittel A; MVZ Ärzteforum Seestraße, Seestraße 64, 13347, Berlin, Germany., Wierecky J; Onkologische Schwerpunktpraxis, Speersort 8 3OG, 20095, Hamburg, Germany., Boller E; iOMEDICO Clinical Research, Hanferstr. 28, 79108, Freiburg, Germany., Indorf M; iOMEDICO Clinical Research, Hanferstr. 28, 79108, Freiburg, Germany., Wörns MA; 1. Med. Klinik, Universitätsmedizin Mainz, Langenbeckstr. 1, 55131, Mainz, Germany., Galle PR; 1. Med. Klinik, Universitätsmedizin Mainz, Langenbeckstr. 1, 55131, Mainz, Germany., Moehler M; 1. Med. Klinik, Universitätsmedizin Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2017 Jun; Vol. 143 (6), pp. 1023-1034. Date of Electronic Publication: 2017 Feb 14.

نوع المنشور: Clinical Trial, Phase IV; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE